Supervisory Board

Dr Jörg Spiekerkötter, Chairman of the Supervisory Board

Dr Jörg Spiekerkötter is a member of PAION’s Supervisory Board since August 2008. Dr Jörg Spiekerkötter has many years of experience in the pharmaceutical industry where he has held executive positions in the areas of finance, law and human resources. Until May 2007, he was the Chief Financial Officer of Organon BioSciences N.V., Oss (Netherlands). He left after the acquisition of the company by the US pharmaceutical company Schering-Plough. Until September 2006, he was the Chief Financial Officer at Schering AG in Berlin (Germany), and before that Head of the Legal Department at Hoechst Schering AgrEvo GmbH in Berlin (Germany). Dr Spiekerkötter studied in Bielefeld (Germany), Lausanne (Switzerland) and Freiburg (Germany) and has a Ph.D. in law. Until December 2010, he was the Chief Financial Officer of Conergy AG, Hamburg (Germany). On 19 May 2010, PAION’s Supervisory Board appointed Dr Spiekerkötter as its Chairman.

Dr Harald F. Stock, Vice Chairman of the Supervisory Board

Dr Harald F. Stock, member of PAION’s Supervisory Board since May 2011, studied Chemistry and Business Administration in the USA, Great Britain and Germany and received a PhD in inorganic chemistry from University of Heidelberg in 1997. He started his career in healthcare as a key account manager at Hestia Pharma. Thereafter he held various positions of increasing responsibilities in local and global functions and corporate divisions of the Roche Group, until in 2005 he was appointed Senior Vice President of the global Near Patient Testing sector in Graz. From 2006 until end of 2008 he was Chairman and Managing Director of the German DePuy Group, the Orthopaedics Division of Johnson&Johnson. Between April and December 2008, he in addition represented Johnson&Johnson on the Board of BVMed, the German Medical Technology Industry Association. In January 2009 he was appointed Chief Executive Officer of the Grünenthal Group based in Aachen. Harald F. Stock also has been a Board Observer on the Board of Directors of ConforMIS, Inc., Burlington, MA, USA since 2009 and was appointed Member of the Board for immatics biotechnologies GmbH, Tübingen, Germany, in February 2011. 

Alan Goodman, Member of the Supervisory Board

Alan Goodman is a member of PAION’s Supervisory Board since July 2008. He has over 30 years’ experience in commerce and industry. On becoming a Fellow of the Chartered Institute of Management Accountants he held senior roles in finance and general management. He is a leading biotechnology entrepreneur having founded or co-founded many biotechnology and healthcare companies, including Agricultural Genetics Company, Medeva plc, Chiroscience Group plc, Acambis plc, Oxford BioMedica plc, CeNeS Pharmaceuticals plc, Core Group plc, Amura Ltd, Crescendo Biologics Ltd and the venture fund Avlar Bioventures Ltd.
He was Chief Executive of Chiros Ltd and Acambis plc, non-executive Chairman of Oxford BioMedica plc and Chairman of CeNeS plc. He currenly is Chief Executive of Avlar BioVentures Ltd; the Manager of three venture capital life science funds, and is also a director of a number of private companies.